Austria Insulin Industry Outlook 2022 - 2026

Key Market Indicators

Austrian insulin imports are projected to reach 138,090 kilograms by 2026, growing at a rate of 0.2% annually. Since 1999, Austrian demand has increased 4.7% each year. In 2021, the country ranked 38th in the world, while Slovakia came in ahead with 139,120 kilograms. France, Germany, and the United Kingdom followed respectively as the second, third, and fourth highest importers. Austrian insulin exports, however, decreased 57.8% in 2018 to 2,270 kilograms, down from 5,370 kilograms the year prior. Since 1999, the country's supply has risen 24.5% annually. In 2018, Austria ranked 38th in the world, while Morocco was the highest exporter with 2,270 kilograms. India, Italy, and Germany followed respectively as the second, third, and fourth biggest suppliers.

Austria Insulin Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Insulin Market Trends: Unraveling Growth, Top Players, and Future Projections

  The insulin sector is experiencing meaningful growth, driven primarily by the increasing prevalence of diabetes globally. The extensive research and development activities in the field of diabetes management have facilitated the advent of innovative insulin delivery systems which has spurred market growth. Moreover, significant enhancements in insulin formulations in terms...

  Discover more insights

• Global Insulin Market: Comprehensive Insights into Size, Trends, and Impact Factors

  The scope of the global insulin market is primarily driven by factors like the prevalence of diabetes, technological advancements in insulin delivery systems, and the rise of obesity. The growing diabetic population across the world necessitates increased insulin production, thereby inflating the market size. Moreover, advancements in technology are facilitating...

  Discover more insights

• Deep-Dive into the Diverse Insulin Market: Key Products, Diabetes Types, and Segmentation Insights

  The Insulin market is populated with an array of products categorized mainly into basal, rapid-acting, traditional, and premixed insulins. Basal and rapid-acting insulin products, such as insulin glargine and insulin lispro, maintain a dominant presence due to their critical role in diabetes management. Traditional human insulins, despite their lower cost,...

  Discover more insights

• Diabetes Care: Navigating Insulin Delivery Trends - Pumps, Syringes, Pens and Modern Innovations

  Conventional methods for insulin delivery, primarily syringes and insulin pens, have been undergoing substantial enhancements. Syringes, although more cost-effective, lack the convenience and precision offered by pens. Insulin pens, on the other hand, have been evolved to offer enhanced ease-of-use, enabling patients to self-administer insulin with more flexibility, catering to...

  Discover more insights

• Insulin Markets: Comparative Examination for Key Global Regions

  The world insulin market shows considerable variation across different geographical regions. The industrialized countries, primarily North America and Europe, continue to dominate in both production and consumption. The U.S. alone accounts for a substantial share of the global insulin market, driven by a large patient population and technological advancements. Europe...

  Discover more insights